Search

Your search keyword '"Eid AA"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Eid AA" Remove constraint Author: "Eid AA"
134 results on '"Eid AA"'

Search Results

51. Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer's Disease and Depression.

52. Prevalence of erectile dysfunction in Egyptian males with metabolic syndrome.

53. COVID-19 and diabetes mellitus: how one pandemic worsens the other.

54. Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders.

55. NETosis contributes to the pathogenesis of diabetes and its complications.

56. The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy.

57. Noninvasive, wearable, and tunable electromagnetic multisensing system for continuous glucose monitoring, mimicking vasculature anatomy.

58. Modulation of radiation-induced damage of human glomerular endothelial cells by SMPDL3B.

59. Seminal levels of angiotensin II and angiotensin II type 2 receptor expression on spermatozoa in varicocele patients: Relation to fertility status.

60. Targeting the NADPH Oxidase-4 and Liver X Receptor Pathway Preserves Schwann Cell Integrity in Diabetic Mice.

61. Role of the Nox4/AMPK/mTOR signaling axe in adipose inflammation-induced kidney injury.

62. Promising anti-diabetic effect of dextran sulfate sodium: Is it its clinical come back?

63. Butyrate modulates diabetes-linked gut dysbiosis: epigenetic and mechanistic modifications.

64. The effect of combined corticotomy and low level laser therapy on the rate of orthodontic tooth movement: split mouth randomized clinical trial.

65. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer.

66. Amelioration of perivascular adipose inflammation reverses vascular dysfunction in a model of nonobese prediabetic metabolic challenge: potential role of antidiabetic drugs.

67. Itraconazole lipid nanocapsules gel for dermatological applications: In vitro characteristics and treatment of induced cutaneous candidiasis.

69. Evaluation of different factors influencing objective measurement of skin color by colorimetry.

70. Novel triazine-based pyrimidines suppress glomerular mesangial cells proliferation and matrix protein accumulation through a ROS-dependent mechanism in the diabetic milieu.

71. Prospective evaluation of the management of bowel dysfunction in children with neuropathic lower urinary tract dysfunction and its effect on bladder dynamics.

72. MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes.

73. Estrogen in vascular smooth muscle cells: A friend or a foe?

74. Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.

75. Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction.

76. Liver X Receptor exerts a protective effect against the oxidative stress in the peripheral nerve.

77. Transforming growth factor-β1 and phosphatases modulate COX-2 protein expression and TAU phosphorylation in cultured immortalized podocytes.

78. Homeostatic effect of laughter on diabetic cardiovascular complications: The myth turned to fact.

79. Translational Aspects of Sphingolipid Metabolism in Renal Disorders.

80. CYP4A/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats.

81. Traumatic brain injury, diabetic neuropathy and altered-psychiatric health: The fateful triangle.

82. Skin permeability enhancement by Bacillus subtilis alkaline protease: Application to transdermal drug delivery.

83. Paraquat Induces Peripheral Myelin Disruption and Locomotor Defects: Crosstalk with LXR and Wnt Pathways.

84. Laparoendoscopic single-site surgery for the treatment of different urological pathologies: Defining the learning curve of an experienced laparoscopist.

85. Assessment of antisperm antibodies in a sample of Egyptian patients with hepatitis C virus infection.

86. Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases.

87. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.

88. Serum level of interleukin-17A in patients with alopecia areata and its relationship to age.

89. Histopathologic and Ultrastructural Changes in Seminiferous Tubules of Adult Male Albino Rats Following Daily Administration of Different Doses of Tadalafil.

90. Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidines.

91. The role of NADPH-derived reactive oxygen species production in the pathogenesis of endometriosis: a novel mechanistic approach.

92. Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine.

93. Seminal Tumour necrosis factor-related apoptosis-inducing ligand and its relationship to infertility in Egyptian patients with varicocele.

94. Thiazole derivatives as inhibitors of cyclooxygenases in vitro and in vivo.

95. Cleavage site stability of Egyptian highly pathogenic avian influenza viruses in backyard chickens during 2009-2011.

96. Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene.

97. Quality of obturation achieved by an endodontic core-carrier system with crosslinked gutta-percha carrier in single-rooted canals.

98. Effects of tricalcium silicate cements on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells in vitro.

99. Ability of new obturation materials to improve the seal of the root canal system: a review.

100. In vitro biocompatibility and oxidative stress profiles of different hydraulic calcium silicate cements.

Catalog

Books, media, physical & digital resources